Ticker ALBO – Albireo Pharma – sales, description, marketcap – Tickerday.com

ALBO

Albireo Pharma

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 628.54M; Volume: 39.74K; AvgVol 3m: 393.50K; Beta: 1.43;

Cost estimate:

P/E: –; EPS: -5.92; EPS growth quarter/prev quarter: -2.20%;

EPS growth this year: -28.00%; EPS growth past 5 years: 18.10%;

EPS ttm: -5.92;

P/S: 61.06; P/B: 5.99; P/Cashflow: 4.54; P/FCF: ;

Sales: 11.28M; Sales growth quarter/prev quarter: 46.20%; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -46.40%; ROE – return on equity: -82.10%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 0.30%; Insider Transactions:;

Institutional Ownership: 60.20%; Institutional Transactions: -1.88%;

Data update: 07.10.2020.